Baker Bros. Advisors LP Selecta Biosciences Inc Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$12.07 - $16.0 $1.13 Million - $1.5 Million	-93,750 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$8.49 - $11.82 $1.61 Million - $2.25 Million	-189,966 Reduced 66.96%	93,750 $955,000
Q4 2017 Feb 14, 2018	SELL	$8.97 - $23.38 $54,654 - $142,454	-6,093 Reduced 2.1%	283,716 $2.78 Million
Q3 2017 Nov 14, 2017	BUY	$15.22 - $20.03 $4.41 Million - $5.8 Million	289,809	289,809 $5.29 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.